Myomo, Inc. (MYO) key performance indicators and operating metrics (13 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Remaining Performance Obligations Backlog Units | 226.00 | FY2026-Q1 |
| MyoPro Units for Which Revenue Was Recognized | 172.00 | FY2026-Q1 |
| Medically Qualified Patients Added to the MyoPro Pipeline | 723.00 | FY2026-Q1 |
| MyoPro Units with Orders and Insurance Authorizations Received | 239.00 | FY2026-Q1 |
| Cost Per Pipeline Add | 2.55K | FY2026-Q1 |
| Average Selling Price | 58.8K | FY2026-Q1 |
| Recurring Patient Sources Percentage of Revenue | 49.00 percent | FY2026-Q1 |
| Medicare Part B Patients Percentage of Revenue | 49.00 percent | FY2025-Q4 |
| Intra-Quarter Orders as a Percentage of Revenue Units | 62.00 percent | FY2025-Q4 |
| Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization | -2.7M | FY2025-Q3 |
| Revenue Units | 178.00 | FY2025-Q2 |
| Total MyoPro Candidates in the Patient Pipeline | 1.61K | FY2025-Q2 |
| Revenue from Medicare Part B Patients | 56.00 percent | FY2025-Q2 |
Back to MYO overview · MYO earnings · MYO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.